ROSEN, A LEADING NATIONAL FIRM, Encourages Block, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SQ, XYZ — Neutral
SQ XYZ GlobeNewsWire — February 11, 2025NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Block, Inc. (NYSE: SQ, XYZ) between February 26, 2020 and April 30, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2025 lead plaintiff deadline.
Arvinas, Inc. (ARVN) Q4 2024 Earnings Call Transcript — Neutral
ARVN Seeking Alpha — February 11, 2025Arvinas, Inc. (NASDAQ:ARVN ) Q4 2024 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Jeff Boyle - Vice President of Investor Relations John Houston - President and Chief Executive Officer Noah Berkowitz - Chief Medical Officer Angela Cacace - Chief Scientific Officer Andrew Saik - Chief Financial Officer Conference Call Participants Derek Archila - Wells Fargo & Company Jonathan Miller - Evercore ISI Li Watsek - Cantor Fitzgerald Akash Tewari - Jefferies Group LLC Tazeen Ahmad - Bank of America Srikripa Devarakonda - Truist Securities Jeet Mukherjee - BTIG, LLC Bradley Canino - Stifel Financial Corp. Sudan …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TELUS International (Cda) Inc. of Class Action Lawsuit and Upcoming Deadlines - TIXT — Neutral
TIXT PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("Telus" or the "Company") (NYSE:TIXT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Newmont Corporation of Class Action Lawsuit and Upcoming Deadlines - NEM — Neutral
NEM PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Newmont Corporation ("Newmont" or the "Company") (NYSE:NEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK — Neutral
GSK PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dominion Energy, Inc. - D — Neutral
D PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dominion Energy, Inc. ("Dominion" or the "Company") (NYSE: D). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI — Neutral
OMI PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Olin Corporation. - OLN — Neutral
OLN PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE:OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Manhattan Associates, Inc. - MANH — Neutral
MANH PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Manhattan Associates, Inc. ("Manhattan Associates" or the "Company") (NASDAQ: MANH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO — Neutral
NVO PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ: NVO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Proficient Auto Logistics, Inc. - PAL — Neutral
PAL PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Proficient Auto Logistics, Inc. ("Proficient Auto Logistics" or the "Company") (NASDAQ: PAL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Primis Financial Corp. - FRST — Neutral
FRST PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Primis Financial Corp. ("Primis" or the "Company") (NASDAQ: FRST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, Inc - CRGX — Neutral
CRGX PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("Cargo" or the "Company") (NASDAQ: CRGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL — Neutral
ZNTL PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc. ("Zentalis" or the "Company") (NASDAQ: ZNTL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Grocery Outlet Holding Corp of Class Action Lawsuit and Upcoming Deadlines - GO — Neutral
GO PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Integral Ad Science Holding Corp. - IAS — Neutral
IAS PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS" or the "Company") (NASDAQ: IAS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ModivCare, Inc. of Class Action Lawsuit and Upcoming Deadlines - MODV — Neutral
MODV PRNewsWire — February 11, 2025NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
KBRA Assigns Preliminary Ratings to Angel Oak Mortgage Trust 2025-2 (AOMT 2025-2) — Neutral
AOMR Business Wire — February 11, 2025NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to seven classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2025-2 (AOMT 2025-2), a $263.1 million non-prime RMBS transaction. The underlying collateral, comprised of 497 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. All the loans are either classified as non-qualified mortgages (57.8%) or exempt (42.2%) from the Ability-to-Repay/Q.
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns — Negative
RGNX Benzinga — February 11, 2025Goldman Sachs downgraded Regenxbio Inc RGNX, citing gene therapy's appeal for wet AMD and diabetic retinopathy is uncertain, as most patients are elderly and newer anti-VEGF treatments offer longer-lasting effects at lower costs.
Sonos Will Survive This Transitional Period, But It Will Take Time — Positive
SONO Seeking Alpha — February 11, 2025Shares of Sonos have continued to wobble after a very strong Q1 earnings print, reflecting investors' nervousness after the company's app update fiasco. The company achieved a strong earnings beat in Q1, with its revenue decline of -10% y/y landing much better than the -15% y/y that Wall Street had feared. The company is freshly cutting 12% of its workforce (after already laying off staff last August), aiming for $60-$70 million in annual savings that potentially turn around adjusted EBITDA this year.
